{"title":"人乳头瘤病毒与胸腺癌之间的关系:一项基于人群的队列研究","authors":"Peng-Tzu Liu, Wan-Lun Hsu, Tzu-I Chen, Chung-Ju Chiang, Mei-Hung Pan, Hui-Ling Lee, Chia-Chuan Wang, Chien-Jen Chen, Vinchi Wang, Yong-Chen Chen","doi":"10.2147/CMAR.S537425","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thymic carcinoma is an uncommon malignancy with unclear etiology. Although human papillomavirus (HPV) has been implicated in multiple cancers, its potential association with thymic cancer remains poorly studied in large population-based cohorts. This study aimed to investigate the role of HPV in developing thymic cancer and the risk of different HPV genotypes on thymic cancer.</p><p><strong>Methods: </strong>We examined the longitudinal relationship between HPV infection and thymic cancer in a cohort of 10,558 women aged 30 to 65 years who were enrolled in 1991 or 1992 in Taiwan. Cervical cells collected at the beginning of this study were tested for 39 types of HPV. The incidence of newly developed thymic cancer was determined through a computerized linkage with the National Cancer Registry by using the topography code 164 for thymic cancer in the International Classification of Diseases, Ninth Edition.</p><p><strong>Results: </strong>An increased risk of thymic cancer was associated with HPV infection, with an HR (95% CI) of 2.42 (0.62 to 9.38) after adjustment for age and body mass index. The level of risk was higher for infections with HPV types classified in the International Agency for Research on Cancer group 3, with an adjusted HR (95% CI) of 11.82 (2.51 to 55.70).</p><p><strong>Conclusion: </strong>This population-based cohort study provides longitudinal evidence that HPV infection may be associated with an increased risk of thymic cancer. While no significant overall association was observed, subgroup analysis revealed a notable association with HPV genotypes classified as IARC group 3. Additional studies are necessary to confirm the role of HPV in thymic carcinogenesis.</p>","PeriodicalId":9479,"journal":{"name":"Cancer Management and Research","volume":"17 ","pages":"2023-2033"},"PeriodicalIF":2.6000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12450386/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association Between Human Papillomavirus and Thymic Cancer: A Population-Based Cohort Study.\",\"authors\":\"Peng-Tzu Liu, Wan-Lun Hsu, Tzu-I Chen, Chung-Ju Chiang, Mei-Hung Pan, Hui-Ling Lee, Chia-Chuan Wang, Chien-Jen Chen, Vinchi Wang, Yong-Chen Chen\",\"doi\":\"10.2147/CMAR.S537425\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Thymic carcinoma is an uncommon malignancy with unclear etiology. Although human papillomavirus (HPV) has been implicated in multiple cancers, its potential association with thymic cancer remains poorly studied in large population-based cohorts. This study aimed to investigate the role of HPV in developing thymic cancer and the risk of different HPV genotypes on thymic cancer.</p><p><strong>Methods: </strong>We examined the longitudinal relationship between HPV infection and thymic cancer in a cohort of 10,558 women aged 30 to 65 years who were enrolled in 1991 or 1992 in Taiwan. Cervical cells collected at the beginning of this study were tested for 39 types of HPV. The incidence of newly developed thymic cancer was determined through a computerized linkage with the National Cancer Registry by using the topography code 164 for thymic cancer in the International Classification of Diseases, Ninth Edition.</p><p><strong>Results: </strong>An increased risk of thymic cancer was associated with HPV infection, with an HR (95% CI) of 2.42 (0.62 to 9.38) after adjustment for age and body mass index. The level of risk was higher for infections with HPV types classified in the International Agency for Research on Cancer group 3, with an adjusted HR (95% CI) of 11.82 (2.51 to 55.70).</p><p><strong>Conclusion: </strong>This population-based cohort study provides longitudinal evidence that HPV infection may be associated with an increased risk of thymic cancer. While no significant overall association was observed, subgroup analysis revealed a notable association with HPV genotypes classified as IARC group 3. Additional studies are necessary to confirm the role of HPV in thymic carcinogenesis.</p>\",\"PeriodicalId\":9479,\"journal\":{\"name\":\"Cancer Management and Research\",\"volume\":\"17 \",\"pages\":\"2023-2033\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12450386/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Management and Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/CMAR.S537425\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Management and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CMAR.S537425","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:胸腺癌是一种罕见的恶性肿瘤,病因不明。尽管人乳头瘤病毒(HPV)与多种癌症有关,但在基于大量人群的队列中,对其与胸腺癌的潜在关联的研究仍然很少。本研究旨在探讨HPV在发生胸腺癌中的作用以及不同HPV基因型对胸腺癌的风险。方法:我们研究了1991年或1992年在台湾登记的10,558名年龄在30至65岁之间的女性HPV感染与胸腺癌之间的纵向关系。在本研究开始时收集的宫颈细胞进行了39种HPV的检测。新发展的胸腺癌的发病率是通过与国家癌症登记处的计算机联系来确定的,使用的是国际疾病分类第九版胸腺癌的地形代码164。结果:胸腺癌风险增加与HPV感染相关,调整年龄和体重指数后的HR (95% CI)为2.42(0.62至9.38)。感染国际癌症研究机构(International Agency for Research on Cancer)第3组分类的HPV类型的风险水平更高,调整后的风险比(95% CI)为11.82(2.51至55.70)。结论:这项基于人群的队列研究提供了纵向证据,表明HPV感染可能与胸腺癌风险增加有关。虽然没有观察到明显的总体关联,但亚组分析显示与IARC分类为第3组的HPV基因型有显著关联。需要进一步的研究来证实HPV在胸腺癌发生中的作用。
Association Between Human Papillomavirus and Thymic Cancer: A Population-Based Cohort Study.
Background: Thymic carcinoma is an uncommon malignancy with unclear etiology. Although human papillomavirus (HPV) has been implicated in multiple cancers, its potential association with thymic cancer remains poorly studied in large population-based cohorts. This study aimed to investigate the role of HPV in developing thymic cancer and the risk of different HPV genotypes on thymic cancer.
Methods: We examined the longitudinal relationship between HPV infection and thymic cancer in a cohort of 10,558 women aged 30 to 65 years who were enrolled in 1991 or 1992 in Taiwan. Cervical cells collected at the beginning of this study were tested for 39 types of HPV. The incidence of newly developed thymic cancer was determined through a computerized linkage with the National Cancer Registry by using the topography code 164 for thymic cancer in the International Classification of Diseases, Ninth Edition.
Results: An increased risk of thymic cancer was associated with HPV infection, with an HR (95% CI) of 2.42 (0.62 to 9.38) after adjustment for age and body mass index. The level of risk was higher for infections with HPV types classified in the International Agency for Research on Cancer group 3, with an adjusted HR (95% CI) of 11.82 (2.51 to 55.70).
Conclusion: This population-based cohort study provides longitudinal evidence that HPV infection may be associated with an increased risk of thymic cancer. While no significant overall association was observed, subgroup analysis revealed a notable association with HPV genotypes classified as IARC group 3. Additional studies are necessary to confirm the role of HPV in thymic carcinogenesis.
期刊介绍:
Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:
◦Epidemiology, detection and screening
◦Cellular research and biomarkers
◦Identification of biotargets and agents with novel mechanisms of action
◦Optimal clinical use of existing anticancer agents, including combination therapies
◦Radiation and surgery
◦Palliative care
◦Patient adherence, quality of life, satisfaction
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.